Regulatory Drug Advertising and Promotion
Optimizing your marketing strategies to meet regulatory compliance
Our team consults on advertising and promotional activities to align with Canadian Advertising Codes and Standards (such as PAAB/ ASC, Innovative Medicines Canada) for Healthcare Professionals (HCP), Patients and Consumers Advertising of Prescription Drugs. We offer vast knowledge and experience in the Pharmaceutical Advertising Regulatory framework.
Regulatory Drug Advertising & Promotions Consulting
Pre-Market Review
- Consultation on the use of global vs. local advertising concepts
- Product Monograph review
- Review Advertising Launch materials
- Pre-NOC messaging
- Consultation on Direct-to-Consumer Information (DTCI)
Marketed Products
- Advertising complaints and provide guidance on the PAAB complaint process
- Review advertising materials; Directed to Healthcare Professional (HCP), Patient-directed materials
- Consultation on promotional activities; Use of reprints, Online promotions, Websites, Learning activities
- Use of global initiatives into the Canadian market
- Direct-to-Consumer Advertising and Information (DTCA/DTCI)